Insulin aspart/insulin protamine aspart - Novo Nordisk
At a glance
- Drug Originator Novo Nordisk
- Drug Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
- USA Patent Applicants NOVO NORDISK INC
- USA Patents 13
- BLAs 2
- International Patents 204

Disclaimer